Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2
The metabotropic glutamate receptor 2 (mGlu2) plays an important role in the presynaptic control of glutamate release and several mGlu2 positive allosteric modulators (PAMs) have been under assessment for their potential as antipsychotics. The binding mode of mGlu2 PAMs is better characterized in fu...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 2017-03, Vol.115, p.115-127 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 127 |
---|---|
container_issue | |
container_start_page | 115 |
container_title | Neuropharmacology |
container_volume | 115 |
creator | Lundström, L. Bissantz, C. Beck, J. Dellenbach, M. Woltering, T.J. Wichmann, J. Gatti, S. |
description | The metabotropic glutamate receptor 2 (mGlu2) plays an important role in the presynaptic control of glutamate release and several mGlu2 positive allosteric modulators (PAMs) have been under assessment for their potential as antipsychotics. The binding mode of mGlu2 PAMs is better characterized in functional terms while few data are available on the relationship between allosteric and orthosteric binding sites. Pharmacological studies characterizing binding and effects of two different chemical series of mGlu2 PAMs are therefore carried out here using the radiolabeled mGlu2 agonist 3[H]-LY354740 and mGlu2 PAM 3[H]-2,2,2-TEMPS. A multidimensional approach to the PAM mechanism of action shows that mGlu2 PAMs increase the affinity of 3[H]-LY354740 for the orthosteric site of mGlu2 as well as the number of 3[H]-LY354740 binding sites. 3[H]-2,2,2-TEMPS binding is also enhanced by the presence of LY354740. New residues in the allosteric rat mGlu2 binding pocket are identified to be crucial for the PAMs ligand binding, among these Tyr3.40 and Asn5.46. Also of remark, in the described experimental conditions S731A (Ser5.42) residue is important only for the mGlu2 PAM LY487379 and not for the compound PAM-1: an example of the structural differences among these mGlu2 PAMs. This study provides a summary of the information generated in the past decade on mGlu2 PAMs adding a detailed molecular investigation of PAM binding mode. Differences among mGlu2 PAM compounds are discussed as well as the mGlu2 regions interacting with mGlu2 PAM and NAM agents and residues driving mGlu2 PAM selectivity.
This article is part of the Special Issue entitled ‘Metabotropic Glutamate Receptors, 5 years on’.
•The characterization of the mechanism of action of two MGLU2 PAMs, using both functional and affinity assays, shows the presence of some level of cooperativity between allosteric and orthosteric sites.•This large mutagenesis study completes the current understanding of the key residues relevant for positive allosterism.•The combination of affinity and functional studies is proposed as a relevant strategy for the definition of the structural changes associated with receptor activation in presence of a positive allosteric modulators. |
doi_str_mv | 10.1016/j.neuropharm.2016.08.040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1870646277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390817300503</els_id><sourcerecordid>1870646277</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-3e8391cdd24ddcf8851dbab8f4211e1b77496af9e2bffef4272c447f8850776a3</originalsourceid><addsrcrecordid>eNqFkc1u3SAQhVHVqrlJ-goVy27sACaGu2yi_kSK1Kpq1wjDOOEKGwdwpHbdB-9YN02XXSFmvjMD5xBCOWs54_3FoZ1hzWm5t3lqBVZaplsm2Quy41p1jWK9fEl2jAnddHumT8hpKQfGmNRcvyYnQgve43VHfn-DJYe50jTSr9s461JMd8HZSO3s6ZQiuDXaTB12rauQwy9bQ5o3Rb0HuqQSangEamNMZes7VHnU1JTLRk1Q7ZAqvhdbd3GtdrIVaAYHCzJUnJNXo40F3jydZ-THxw_frz83t18-3Vy_v21cp2RtOtDdnjvvhfTejVpfcj_YQY9ScA58UEruezvuQQzjCFhVwkmpNpAp1dvujLw7zl1yelihVDOF4iBGO0Nai0Hv0LheKIWoPqIup1IyjAZtmmz-aTgzWwbmYP5lYLYMDNMGM0Dp26ct6zCBfxb-NR2BqyMA-NfHANkUF2B24AN6Uo1P4f9b_gBiu6Gp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1870646277</pqid></control><display><type>article</type><title>Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lundström, L. ; Bissantz, C. ; Beck, J. ; Dellenbach, M. ; Woltering, T.J. ; Wichmann, J. ; Gatti, S.</creator><creatorcontrib>Lundström, L. ; Bissantz, C. ; Beck, J. ; Dellenbach, M. ; Woltering, T.J. ; Wichmann, J. ; Gatti, S.</creatorcontrib><description>The metabotropic glutamate receptor 2 (mGlu2) plays an important role in the presynaptic control of glutamate release and several mGlu2 positive allosteric modulators (PAMs) have been under assessment for their potential as antipsychotics. The binding mode of mGlu2 PAMs is better characterized in functional terms while few data are available on the relationship between allosteric and orthosteric binding sites. Pharmacological studies characterizing binding and effects of two different chemical series of mGlu2 PAMs are therefore carried out here using the radiolabeled mGlu2 agonist 3[H]-LY354740 and mGlu2 PAM 3[H]-2,2,2-TEMPS. A multidimensional approach to the PAM mechanism of action shows that mGlu2 PAMs increase the affinity of 3[H]-LY354740 for the orthosteric site of mGlu2 as well as the number of 3[H]-LY354740 binding sites. 3[H]-2,2,2-TEMPS binding is also enhanced by the presence of LY354740. New residues in the allosteric rat mGlu2 binding pocket are identified to be crucial for the PAMs ligand binding, among these Tyr3.40 and Asn5.46. Also of remark, in the described experimental conditions S731A (Ser5.42) residue is important only for the mGlu2 PAM LY487379 and not for the compound PAM-1: an example of the structural differences among these mGlu2 PAMs. This study provides a summary of the information generated in the past decade on mGlu2 PAMs adding a detailed molecular investigation of PAM binding mode. Differences among mGlu2 PAM compounds are discussed as well as the mGlu2 regions interacting with mGlu2 PAM and NAM agents and residues driving mGlu2 PAM selectivity.
This article is part of the Special Issue entitled ‘Metabotropic Glutamate Receptors, 5 years on’.
•The characterization of the mechanism of action of two MGLU2 PAMs, using both functional and affinity assays, shows the presence of some level of cooperativity between allosteric and orthosteric sites.•This large mutagenesis study completes the current understanding of the key residues relevant for positive allosterism.•The combination of affinity and functional studies is proposed as a relevant strategy for the definition of the structural changes associated with receptor activation in presence of a positive allosteric modulators.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2016.08.040</identifier><identifier>PMID: 28216000</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Allosteric Regulation - drug effects ; Allosteric Regulation - physiology ; Animals ; Binding Sites - physiology ; Bridged Bicyclo Compounds - chemistry ; Bridged Bicyclo Compounds - metabolism ; Bridged Bicyclo Compounds - pharmacology ; Excitatory Amino Acid Agonists - chemistry ; Excitatory Amino Acid Agonists - metabolism ; Excitatory Amino Acid Agonists - pharmacology ; Glutamic Acid - metabolism ; Glutamic Acid - pharmacology ; Humans ; LY354740 ; LY487379 ; Metabotropic glutamate receptor ; mGlu2 ; mGlu3 ; mGluR ; Negative allosteric modulators ; Positive allosteric modulators ; Protein Structure, Secondary ; Receptors, Metabotropic Glutamate - agonists ; Receptors, Metabotropic Glutamate - physiology</subject><ispartof>Neuropharmacology, 2017-03, Vol.115, p.115-127</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-3e8391cdd24ddcf8851dbab8f4211e1b77496af9e2bffef4272c447f8850776a3</citedby><cites>FETCH-LOGICAL-c374t-3e8391cdd24ddcf8851dbab8f4211e1b77496af9e2bffef4272c447f8850776a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0028390817300503$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28216000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lundström, L.</creatorcontrib><creatorcontrib>Bissantz, C.</creatorcontrib><creatorcontrib>Beck, J.</creatorcontrib><creatorcontrib>Dellenbach, M.</creatorcontrib><creatorcontrib>Woltering, T.J.</creatorcontrib><creatorcontrib>Wichmann, J.</creatorcontrib><creatorcontrib>Gatti, S.</creatorcontrib><title>Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The metabotropic glutamate receptor 2 (mGlu2) plays an important role in the presynaptic control of glutamate release and several mGlu2 positive allosteric modulators (PAMs) have been under assessment for their potential as antipsychotics. The binding mode of mGlu2 PAMs is better characterized in functional terms while few data are available on the relationship between allosteric and orthosteric binding sites. Pharmacological studies characterizing binding and effects of two different chemical series of mGlu2 PAMs are therefore carried out here using the radiolabeled mGlu2 agonist 3[H]-LY354740 and mGlu2 PAM 3[H]-2,2,2-TEMPS. A multidimensional approach to the PAM mechanism of action shows that mGlu2 PAMs increase the affinity of 3[H]-LY354740 for the orthosteric site of mGlu2 as well as the number of 3[H]-LY354740 binding sites. 3[H]-2,2,2-TEMPS binding is also enhanced by the presence of LY354740. New residues in the allosteric rat mGlu2 binding pocket are identified to be crucial for the PAMs ligand binding, among these Tyr3.40 and Asn5.46. Also of remark, in the described experimental conditions S731A (Ser5.42) residue is important only for the mGlu2 PAM LY487379 and not for the compound PAM-1: an example of the structural differences among these mGlu2 PAMs. This study provides a summary of the information generated in the past decade on mGlu2 PAMs adding a detailed molecular investigation of PAM binding mode. Differences among mGlu2 PAM compounds are discussed as well as the mGlu2 regions interacting with mGlu2 PAM and NAM agents and residues driving mGlu2 PAM selectivity.
This article is part of the Special Issue entitled ‘Metabotropic Glutamate Receptors, 5 years on’.
•The characterization of the mechanism of action of two MGLU2 PAMs, using both functional and affinity assays, shows the presence of some level of cooperativity between allosteric and orthosteric sites.•This large mutagenesis study completes the current understanding of the key residues relevant for positive allosterism.•The combination of affinity and functional studies is proposed as a relevant strategy for the definition of the structural changes associated with receptor activation in presence of a positive allosteric modulators.</description><subject>Allosteric Regulation - drug effects</subject><subject>Allosteric Regulation - physiology</subject><subject>Animals</subject><subject>Binding Sites - physiology</subject><subject>Bridged Bicyclo Compounds - chemistry</subject><subject>Bridged Bicyclo Compounds - metabolism</subject><subject>Bridged Bicyclo Compounds - pharmacology</subject><subject>Excitatory Amino Acid Agonists - chemistry</subject><subject>Excitatory Amino Acid Agonists - metabolism</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Glutamic Acid - metabolism</subject><subject>Glutamic Acid - pharmacology</subject><subject>Humans</subject><subject>LY354740</subject><subject>LY487379</subject><subject>Metabotropic glutamate receptor</subject><subject>mGlu2</subject><subject>mGlu3</subject><subject>mGluR</subject><subject>Negative allosteric modulators</subject><subject>Positive allosteric modulators</subject><subject>Protein Structure, Secondary</subject><subject>Receptors, Metabotropic Glutamate - agonists</subject><subject>Receptors, Metabotropic Glutamate - physiology</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u3SAQhVHVqrlJ-goVy27sACaGu2yi_kSK1Kpq1wjDOOEKGwdwpHbdB-9YN02XXSFmvjMD5xBCOWs54_3FoZ1hzWm5t3lqBVZaplsm2Quy41p1jWK9fEl2jAnddHumT8hpKQfGmNRcvyYnQgve43VHfn-DJYe50jTSr9s461JMd8HZSO3s6ZQiuDXaTB12rauQwy9bQ5o3Rb0HuqQSangEamNMZes7VHnU1JTLRk1Q7ZAqvhdbd3GtdrIVaAYHCzJUnJNXo40F3jydZ-THxw_frz83t18-3Vy_v21cp2RtOtDdnjvvhfTejVpfcj_YQY9ScA58UEruezvuQQzjCFhVwkmpNpAp1dvujLw7zl1yelihVDOF4iBGO0Nai0Hv0LheKIWoPqIup1IyjAZtmmz-aTgzWwbmYP5lYLYMDNMGM0Dp26ct6zCBfxb-NR2BqyMA-NfHANkUF2B24AN6Uo1P4f9b_gBiu6Gp</recordid><startdate>20170315</startdate><enddate>20170315</enddate><creator>Lundström, L.</creator><creator>Bissantz, C.</creator><creator>Beck, J.</creator><creator>Dellenbach, M.</creator><creator>Woltering, T.J.</creator><creator>Wichmann, J.</creator><creator>Gatti, S.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170315</creationdate><title>Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2</title><author>Lundström, L. ; Bissantz, C. ; Beck, J. ; Dellenbach, M. ; Woltering, T.J. ; Wichmann, J. ; Gatti, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-3e8391cdd24ddcf8851dbab8f4211e1b77496af9e2bffef4272c447f8850776a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Allosteric Regulation - drug effects</topic><topic>Allosteric Regulation - physiology</topic><topic>Animals</topic><topic>Binding Sites - physiology</topic><topic>Bridged Bicyclo Compounds - chemistry</topic><topic>Bridged Bicyclo Compounds - metabolism</topic><topic>Bridged Bicyclo Compounds - pharmacology</topic><topic>Excitatory Amino Acid Agonists - chemistry</topic><topic>Excitatory Amino Acid Agonists - metabolism</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Glutamic Acid - metabolism</topic><topic>Glutamic Acid - pharmacology</topic><topic>Humans</topic><topic>LY354740</topic><topic>LY487379</topic><topic>Metabotropic glutamate receptor</topic><topic>mGlu2</topic><topic>mGlu3</topic><topic>mGluR</topic><topic>Negative allosteric modulators</topic><topic>Positive allosteric modulators</topic><topic>Protein Structure, Secondary</topic><topic>Receptors, Metabotropic Glutamate - agonists</topic><topic>Receptors, Metabotropic Glutamate - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lundström, L.</creatorcontrib><creatorcontrib>Bissantz, C.</creatorcontrib><creatorcontrib>Beck, J.</creatorcontrib><creatorcontrib>Dellenbach, M.</creatorcontrib><creatorcontrib>Woltering, T.J.</creatorcontrib><creatorcontrib>Wichmann, J.</creatorcontrib><creatorcontrib>Gatti, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lundström, L.</au><au>Bissantz, C.</au><au>Beck, J.</au><au>Dellenbach, M.</au><au>Woltering, T.J.</au><au>Wichmann, J.</au><au>Gatti, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2017-03-15</date><risdate>2017</risdate><volume>115</volume><spage>115</spage><epage>127</epage><pages>115-127</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>The metabotropic glutamate receptor 2 (mGlu2) plays an important role in the presynaptic control of glutamate release and several mGlu2 positive allosteric modulators (PAMs) have been under assessment for their potential as antipsychotics. The binding mode of mGlu2 PAMs is better characterized in functional terms while few data are available on the relationship between allosteric and orthosteric binding sites. Pharmacological studies characterizing binding and effects of two different chemical series of mGlu2 PAMs are therefore carried out here using the radiolabeled mGlu2 agonist 3[H]-LY354740 and mGlu2 PAM 3[H]-2,2,2-TEMPS. A multidimensional approach to the PAM mechanism of action shows that mGlu2 PAMs increase the affinity of 3[H]-LY354740 for the orthosteric site of mGlu2 as well as the number of 3[H]-LY354740 binding sites. 3[H]-2,2,2-TEMPS binding is also enhanced by the presence of LY354740. New residues in the allosteric rat mGlu2 binding pocket are identified to be crucial for the PAMs ligand binding, among these Tyr3.40 and Asn5.46. Also of remark, in the described experimental conditions S731A (Ser5.42) residue is important only for the mGlu2 PAM LY487379 and not for the compound PAM-1: an example of the structural differences among these mGlu2 PAMs. This study provides a summary of the information generated in the past decade on mGlu2 PAMs adding a detailed molecular investigation of PAM binding mode. Differences among mGlu2 PAM compounds are discussed as well as the mGlu2 regions interacting with mGlu2 PAM and NAM agents and residues driving mGlu2 PAM selectivity.
This article is part of the Special Issue entitled ‘Metabotropic Glutamate Receptors, 5 years on’.
•The characterization of the mechanism of action of two MGLU2 PAMs, using both functional and affinity assays, shows the presence of some level of cooperativity between allosteric and orthosteric sites.•This large mutagenesis study completes the current understanding of the key residues relevant for positive allosterism.•The combination of affinity and functional studies is proposed as a relevant strategy for the definition of the structural changes associated with receptor activation in presence of a positive allosteric modulators.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28216000</pmid><doi>10.1016/j.neuropharm.2016.08.040</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2017-03, Vol.115, p.115-127 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_proquest_miscellaneous_1870646277 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Allosteric Regulation - drug effects Allosteric Regulation - physiology Animals Binding Sites - physiology Bridged Bicyclo Compounds - chemistry Bridged Bicyclo Compounds - metabolism Bridged Bicyclo Compounds - pharmacology Excitatory Amino Acid Agonists - chemistry Excitatory Amino Acid Agonists - metabolism Excitatory Amino Acid Agonists - pharmacology Glutamic Acid - metabolism Glutamic Acid - pharmacology Humans LY354740 LY487379 Metabotropic glutamate receptor mGlu2 mGlu3 mGluR Negative allosteric modulators Positive allosteric modulators Protein Structure, Secondary Receptors, Metabotropic Glutamate - agonists Receptors, Metabotropic Glutamate - physiology |
title | Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A13%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reprint%20of%20Pharmacological%20and%20molecular%20characterization%20of%20the%20positive%20allosteric%20modulators%20of%20metabotropic%20glutamate%20receptor%202&rft.jtitle=Neuropharmacology&rft.au=Lundstr%C3%B6m,%20L.&rft.date=2017-03-15&rft.volume=115&rft.spage=115&rft.epage=127&rft.pages=115-127&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2016.08.040&rft_dat=%3Cproquest_cross%3E1870646277%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1870646277&rft_id=info:pmid/28216000&rft_els_id=S0028390817300503&rfr_iscdi=true |